ScholarIQanswers from OpenAlex & ORCID
David R. Byrd
ResearcherPublications, citations & collaboration network
David R. Byrd is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David R. Byrd have?
ScholarIQindexed works
David R. Byrd has 259 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David R. Byrd have?
ScholarIQcitation count
David R. Byrd has 26,613 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David R. Byrd?
ScholarIQh-index
David R. Byrd has an h-index of 57 in OpenAlex.
What is the i10-index of David R. Byrd?
ScholarIQi10-index
David R. Byrd has an i10-index of 116 in OpenAlex.
What is the ORCID of David R. Byrd?
ScholarIQorcid
The ORCID for David R. Byrd is on the source record.
What is the OpenAlex record for David R. Byrd?
ScholarIQopenalex
The OpenAlex for David R. Byrd is on the source record.
What are the most-cited papers on David R. Byrd?
ScholarIQmost cited works
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong, John F. Thompson, Michael B. Atkins, David R. Byrd, Antônio C. Buzaid, Alistair J. Cochran, Daniel G. Coit, Shouluan Ding, Alexander M.M. Eggermont, Keith T. Flaherty, Phyllis A. Gimotty, John M. Kirkwood, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Merrick I. Ross, Arthur J. Sober, Vernon K. Sondak
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Charles M. Balch, Seng‐Jaw Soong, Jeffrey E. Gershenwald, John F. Thompson, Douglas S. Reintgen, Natale Cascinelli, Marshall M. Urist, Kelly M. McMasters, Merrick I. Ross, John M. Kirkwood, Michael B. Atkins, John A. Thompson, Daniel G. Coit, David R. Byrd, Renée A. Desmond, Yuting Zhang, Ping‐Yu Liu, Gary H. Lyman, Aberto Morabito
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert H.I. Andtbacka, Nicola Mozzillo, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Alessandro Testori, Peter D. Beitsch, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Michel W.J.M. Wouters, Michael S. Sabel, Edward A. Levine, Doreen M. Agnese, Michael A. Henderson, Reinhard Dummer, Carlo Riccardo Rossi, Rogerio I. Neves, Steven D. Trocha, Frances C. Wright, David R. Byrd, Maurice Matter, Eddy C. Hsueh, Alastair D. MacKenzie Ross, Douglas B. Johnson, Patrick Terheyden, Adam C. Berger, Tara L. Huston, Jeffrey D. Wayne, B. Mark Smithers, Heather B. Neuman, Schlomo Schneebaum, Jeffrey E. Gershenwald, Charlotte E. Ariyan, Darius C. Desai, Lisa K. Jacobs, Kelly M. McMasters, Anja Gesierich, Peter Hersey, Steven D. Bines, John M. Kane, Richard J. Barth, Gregory McKinnon, Jeffrey M. Farma, Erwin Schultz, Sergi Vidal‐Sicart, Richard Hoefer, James M. Lewis, Randall P. Scheri, Mark C. Kelley, Omgo E. Nieweg, R. Dirk Noyes, Dave S.�B. Hoon, He-Jing Wang, David Elashoff, Robert M. Elashoff
Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases
Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong, John F. Thompson, Shouluan Ding, David R. Byrd, Natale Cascinelli, Alistair J. Cochran, Daniel G. Coit, Alexander M.M. Eggermont, Timothy M. Johnson, John M. Kirkwood, Stanley P. L. Leong, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Merrick I. Ross, Vernon K. Sondak